ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
1.020
-0.020 (-1.92%)
At close: Jun 26, 2026, 4:00 PM EDT
1.049
+0.029 (2.79%)
After-hours: Jun 26, 2026, 7:00 PM EDT
ADC Therapeutics Employees
As of December 31, 2025, ADC Therapeutics had 193 total employees, including 188 full-time and 5 part-time employees. The number of employees decreased by 72 or -27.17% compared to the previous year.
Employees
193
Change (1Y)
-72
Growth (1Y)
-27.17%
Revenue / Employee
$410,233
Profits / Employee
-$709,788
Market Cap
129.73M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Fractyl Health | 100 |
| Agenus | 81 |
| Connect Biopharma Holdings | 64 |
| PepGen | 59 |
| Enlivex | 34 |
| Jyong Biotech | 27 |
| Genelux | 26 |
| Spero Therapeutics | 25 |
ADCT News
- 2 days ago - ADC Therapeutics to reduce workforce by 17% globally - TheFly
- 2 days ago - ADC Therapeutics Announces Strategic Reorganization to Support ZYNLONTA® Growth Opportunities and Regulatory Priorities - PRNewsWire
- 18 days ago - ADC Therapeutics downgraded to Neutral from Buy at H.C. Wainwright - TheFly
- 22 days ago - ADC Therapeutics price target lowered to $5 from $8 at Stephens - TheFly
- 22 days ago - ADC Therapeutics plunges after patient deaths in blood cancer drug trial - Reuters
- 23 days ago - ADC Therapeutics downgraded to Sector Perform from Outperform at RBC Capital - TheFly
- 23 days ago - ADC Therapeutics Transcript: Study result - Transcripts
- 23 days ago - ADC Therapeutics Slides: Study result - Filings